Fig. 3From: Heterologous reconstitution of the biosynthesis pathway for 4-demethyl-premithramycinone, the aglycon of antitumor polyketide mithramycinProposed biosynthesis pathway for 4-demethyl-premithramycinone. Dashed lines represent formation of shunt productsBack to article page